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Abstract
Mitochondrial diseases are a highly complex, heterogeneous group of disorders. Mitochondrial DNA variants that are linked 
to disease can exhibit variable expression and penetrance. This has an implication for mitochondrial diagnostics as variants 
that cause disease in one individual may not in another. It has been suggested that the sequence context in which a variant 
arises could influence the genotype–phenotype relationship. However, the consequence of sequence variation between dif-
ferent haplogroups on the expression of disease is not well understood. European haplogroups are the most widely studied. 
To ensure accurate diagnostics for patients globally, we first need to understand how, if at all, the sequence context in 
which a variant arises contributes to the manifestion of disease. To help us understand this, we used 2752 sequences from 
33 non-human species that do not have disease. We searched for variants in the seven complex I genes that are associated 
with disease in humans. Our findings indicate that only three reported pathogenic complex I variants have arisen in these 
species. More importantly, only one of these, m.3308T>C, has arisen with its associated amino acid change in the studied 
non-human species. With the status of m.3308T>C as a disease causing variant being a matter of debate. This is a stark 
contrast to previous findings in the mitochondrial tRNA genes and suggests that sequence context may be less important in 
the complex I genes. This information will help us improve the identification and diagnosis of mitochondrial DNA variants 
in non-European populations.
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Introduction
Diseases resulting from mitochondrial DNA (mtDNA) 
mutations are a clinically heterogeneous group of disorders 
frequently exhibiting variable penetrance. The prevalence 
of mitochondrial disease is estimated to be approximately 
1 in 4300 within the adult European population (Gorman 
et al. 2015). Assessment of pathogenicity is difficult, requir-
ing evidence from multiple sources to obtain reliable infor-
mation to link a mutation to disease. These difficulties are 
in part due to high levels of mtDNA variation within any 
given population (van Oven and Kayser 2009) and lack of 
standards in the use of evidence to link variants to disease 
(Yarham et al. 2012). European populations remain the 
most widely studied in regards to mitochondrial disease. 
Other populations, such as Black Africans, have been stud-
ied far less and the impact of mitochondrial variants within 
these populations is not yet known (van der Westhuizen 
et al. 2015). It is debated whether haplogroup background 
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influences the penetrance of mtDNA mutations. Some popu-
lations may be more or less susceptible to the pathogenic 
effect of particular mtDNA variants (Ji et al. 2014).
This may partially explain the low diagnosis rates seen 
within non-European populations where population varia-
tion is still less explored. Studying haplogroup background 
and its impact on disease penetrance will help ensure similar 
levels of diagnostic accuracy to all populations (van der Walt 
et al. 2012; van der Westhuizen et al. 2015). One way to 
begin to achieve this increased understanding of the impor-
tance of haplogroup context is by searching for variants, 
which are known to be pathogenic in humans, in other spe-
cies. Magalhães (2005), conducted a search using a single 
mitochondrial genome sequence in each of 12 primate spe-
cies. In total 46 disease-associated variants were found to 
be present in 1 or more of the primates. Magalhães (2005) 
suggests that masking variants may exist which could nullify 
the deleterious effects of pathogenic variants. This supports 
the theory that haplogroup background is important in the 
expression and penetrance of disease in humans. The reper-
toire of disease-associated variants has expanded since the 
publication of this article and clinically validated scoring 
criteria are now available for the assessment of pathogenic-
ity. Similarly, a wealth of publicly available sequences, both 
human and non-human, are now available. Recently, Queen 
et al. (2017) used a significantly expanded collection of 
sequences from multiple chordate species and successfully 
identified human pathogenic variants and possible masking 
variants in mitochondrial tRNA’s (mt-tRNA’s), particularly 
in mt-tRNA-Leu (UUR). In the current paper, pathogenic 
variants of the complex I mtDNA encoded subunits were 
searched for in a collection of 2752 sequences from 33 non-
human species as described previously (2017). We identified 
a single variant, m.3308T>C, that is both reported as patho-
genic in humans (Mezghani et al. 2013; Ding and Zhu 2011; 
Zarrouk Mahjoub et al. 2012) and results in an amino acid 
change in the mtDNA context of the species studied. How-
ever the strength of the evidence to support the pathogenicity 
of this variant has been debated (Salas and Elson 2012). This 
scarcity of disease-associated protein-coding variants seen 
in other species and debate over the pathogenicity of those 
that have been observed is in sharp contrast to what was 
described in the context of the mt-tRNA’s where many more 
pathogenic variants were seen (Queen et al. 2017).
Methods
Identification of Disease‑Associated Variants
The MitoMap database was utilised to identify nucle-
otide variants which have been previously associ-
ated with disease. All nucleotide variants from genes 
which encode mitochondrial complex I were collated. 
(Accessed:02-2017).
Extraction of the Revised Cambridge Reference 
Sequence from the NCBI GenBank Database
The revised Cambridge Reference Sequences (rCRS) for 
human mitochondrial ND1-6 and ND4L were obtained 
from the NCBI GenBank database, NCBI Ref Seq: 
NC_012920.1. The corresponding gene from the rCRS was 
inserted into FASTA files of individual gene sequences 
from non-human species. FASTA files were pre-compiled 
by Queen et al. (2017), as described previously, see Sup-
plementary Table 1.
Gene Alignment and Variant Calling
Species sequence files with the inserted rCRS were 
uploaded into Jalview software (Waterhouse et al. 2009) 
for alignment. Clustal Omega alignments were performed 
with default settings. Nucleotide positions identified 
through MitoMap were located in each sequence align-
ment and assessed for variability from the rCRS.
Pathogenicity Scoring and Assessing 
the Pathogenicity of Amino Acid Substitutions
Pathogenicity scoring was performed on nucleotide vari-
ants identified in the alignments of non-human species. 
This was conducted in accordance with the Mitchell et al. 
(2006) pathogenicity scoring algorithm (Mitchell et al. 
2006). Human amino acid reference sequences were iden-
tified in UniProt as follows: P03886, P03891, P03897, 
P03905, P03915, P03923, P03901. PolyPhen-v2 and 
MutPred1.0 were consulted for amino acid pathogenicity 
predictions as described previously.
Potential Masking Variants and their Presence 
as Population Markers in Human Haplogroups
Alignments were screened for additional variants which 
may mask the deleterious effects of the pathogenic vari-
ants. Putative masking variants were also scored for patho-
genicity. MitoMap and NCBI GenBank were used to search 
for the putative masking variants within populations.
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Results
Classification of Variants Conserved in Non‑human 
Species
Of the 152 complex I variants initially identified as being 
human disease-associated through the MitoMap database 
(Lott et al. 2013a), 87 were found in the complex I genes 
of the non-human species studied here. 11 of these would 
result in synonymous amino acids changes and were not 
investigated further. Pathogenicity was fully assessed 
for each of the remaining 76 variants with the use of the 
Mitchell et al. (2006) pathogenicity scoring algorithm, 
as well as PolyPhen v2 (Adzhubei et al. 2010) and Mut-
Pred1.0 (Li et  al. 2009) mutation prediction software. 
Based on this assessment, three variants were classified as 
definitely pathogenic; 19 as probably pathogenic (Table 1); 
26 as possibly pathogenic and 28 as neutral or polymor-
phic variants, see Supplementary Table 2. Additional data 
relating to GenBank frequency and conservation index for 
each variant listed were obtained using the 45,494 full 
length sequences included in the SNV query tool of Mito-
master (Lott et al. 2013b) (Table 2).
Presence of Pathogenic Variants Within Non‑human 
Species
The m.3308T>C variant was present in 100% of the 
mt-ND1 sequences from species of the Pan genus 
(Table 1). Two additional mt-ND1 variants, m.4205T>C 
and m.4232T>C corresponding to amino acid changes 
L > S and I > T, respectively, were present in the same 
species, but absent in the remaining species. Both are 
thought to be non-pathogenic in humans. The m.4205T>C 
variant is reported in 10/49 R8a haplogroup sequences, 
whereas m.4232T>C is reported in 13/15 haplogroup 
R30a1 sequences and 551/552 haplogroup L0d sequences 
(Benson et al. 2005). A single L0d sequence from human 
population data was shown to carry both the ‘pathogenic’ 
m.3308T>C and the non-pathogenic m.4232T>C (van 
Oven and Kayser 2009).
The m.10191T>C mt-ND3 and m.14487T>C mt-ND6 
human pathogenic variants were identified in non-mamma-
lian Chordata, more specifically, species of fish (Table 1). 
The m.10191T>C variant was found in a single species, 
Hypophthalmichthys molitrix, while m.14487T>C was 
identified in six species. Again, the presence of these vari-
ants was seen in 100% of the sequence alignment from 
each of these species. However, although the m.10191T>C 
causes an S > P amino acid change in humans, an S > L 
amino acid change is seen in Hypophthalmichthys molitrix 
due to variation at all three bases of the codon. Similarly, 
the m.14487T>C variant that would produce an M > V 
change in humans, instead results in an M > G amino acid 
change in all six fish species in which it was identified, 
due to a second variation in the first base of the codon, 
see Fig. 1.
Discussion
The results of this study focussing on the seven mtDNA 
encoded complex I genes differ from the previous study on 
the mt-tRNA genes (Queen et al. 2017) in which three defi-
nitely human pathogenic variants were identified in 100% of 
alignments in a single mt-tRNA gene, mt-tRNA-Leu (UUR), 
and a further two definitely pathogenic variants occurred as 
polymorphic variants in different species. Thus, five human 
definitely pathogenic variants of mt-tRNA-Leu (UUR) were 
either ubiquitous or common in other species. In contrast, 
across all seven mtDNA encoded complex I genes only three 
definitely pathogenic variants were found to be present in the 
non-human sequences; only one of which, m.3308T>C, pre-
sented its associated amino acid alteration in the non-human 
species. Prior work by Magalhães (2005) found 32 patho-
genic variants in the tRNA genes and eight in the complex 
I genes (de Magalhaes 2005), this work being completed 
without the use of agreed algorithms to assign pathogenicity, 
as these were not agreed until after the completion of this 
path finding study.
Importantly, however, the pathogenicity of the 
m.3308T>C variant is contested in some contexts (Salas 
and Elson 2012). Such debates might be expected if a variant 
shows a deleterious effect on one lineage but not on another. 
m.3308T>C is a commonly found mt-ND1 polymorphism in 
some human lineages, which is generally perceived as strong 
evidence against a role in disease under the assumption of 
variants having the same effect in all lineage contexts. It is 
an African L1b and North American A2i haplogroup marker 
and is also evident in a small subset of L2a sequences (van 
Oven and Kayser 2009). However, it is rare in European 
sequences, appearing in 1/1063 J1c sequences and 1/443 
T1a sequences in GenBank (van Oven and Kayser 2009) and 
has been associated with MELAS and sudden infant death 
syndrome in patients with European haplogroups (Opdal 
et al. 1999; Campos et al. 1997). This leads us to consider if 
“out of context” haplogroup variants should be considered 
as candidates for pathogenic changes. In some studies, such 
out of place haplogroup variants have been referred to as 
private changes (Herrnstadt et al. 2002).
Variation at m.3308T>C exchanges the initiation 
codon methionine for a threonine. In humans, an alter-
native initiation codon is found at the third amino acid 
(Opdal et al. 1999). It is thought that this truncation of 
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Table 1  Definitely or Probably pathogenic human mitochondrial variants present in the alignments of one or more chordate species across all 7 
complex I genes
Gene Position Variant Disease association Status Species
ND1 3308 T-C MELAS, SIDS, putative LHON Definitely pathogenic Pan paniscus, Pan troglodytes troglodytes, Pan 
troglodytes schweinfurthii, Pan troglodytes 
verus
3310 C-T Diabetes, hypertrophic cardiomyopathy Probably pathogenic Mus musculus, Mus musculus domesticus, Rat-
tus norvegicus, Myodes glareolus, Bos tau-
rus, Bos grunniens, Ovis aries, Balaenoptera 
physalus, Bison bison, Orcinus orca, Sus 
scrofa, Syncerus caffer, Tursiops truncatus, 
Canis lupus familiaris, Urocyon littoralis 
catalinae, Urocyon littoralis clemente, 
Urocyon littoralis santacruzae, Ursus arctos, 
Ursus spelaeus
3394 T-C LHON, diabetes Probably pathogenic Macaca fascicularis
3890 G-A Progressive encephalomyopathy, LS, optic 
atrophy
Probably pathogenic Sus scrofa
3995 A-G MELAS Probably pathogenic Canis lupus familiaris
4171 C-A LHON Probably pathogenic Anguilla anguilla, Anguilla rostrata, Sus 
scrofa
4216 T-C LHON, insulin resistance Probably pathogenic Mus musculus, Mus musculus domesticus, 
Myodes glareolus, Bos taurus, Bos grun-
niens, Ovis aries, Equus caballus, Hypoph-
thalmichthys molitrix, Hypophthalmichthys 
nobilis, Balaenoptera physalus, Bison bison, 
Orcinus orca, Sus scrofa, Syncerus caffer, 
Tursiops truncatus, Canis lupus familiaris, 
Urocyon littoralis catalinae, Urocyon littora-
lis clemente, Urocyon littoralis santacruzae, 
Ursus arctos, Ursus spelaeus
ND2 4640 C-A LHON Probably pathogenic Mus musculus, Mus musculus domesticus, Rat-
tus norvegicus, Myodes glareolus, Anguilla 
anguilla, Anguilla rostrata, Coregonus 
lavaretus, Glyphis glyphis, Hypophthalmich-
thys molitrix, Hypophthalmichthys nobilis, 
Sus scrofa, Canis lupus familiaris, Ursus 
arctos, Ursus spelaeus
ND3 10,158 T-C Leigh disease Probably pathogenic Anguilla anguilla, Clupea harengus
10,191 T-C Leigh disease Definitely pathogenic Hypophthalmichthys molitrix
ND4 11,240 C-T Leigh disease Probably pathogenic Rattus norvegicus, Bos taurus, Ovis aries, 
Equus caballus, Hypophthalmichthys nobilis, 
Bison bison
11,696 G-A LHON, LHON with dystonia, maternally 
inherited deafness
Probably pathogenic Pan troglodytes troglodytes, Pan troglodytes 
schweinfurthii, Pan troglodytes verus, 
Macaca fascicularis, Mus musculus, Mus 
musculus domesticus, Rattus norvegicus, 
Myodes glareolus, Anguilla rostrata, Bos 
taurus, Ovis aries, Coregonus lavaretus, 
Hypophthalmichthys molitrix, Hypophthal-
michthys nobilis, Balaenoptera physalus, 
Bison bison, Orcinus orca, Sus scrofa, 
Syncerus caffer, Urocyon littoralis catali-
nae, Urocyon littoralis clemente, Urocyon 
littoralis santacruzae, Ursus arctos, Ursus 
spelaeus
ND4L 10,663 T-C LHON Probably pathogenic Anguilla anguilla, Anguilla rostrata, Clupea 
harengus, Coregonus lavaretus, Gallus gal-
lus, Glyphis glyphis, Hypophthalmichthys 
molitrix, Hypophthalmichthys nobilis, Ovis 
aries
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two amino acids may influence the hydrophobicity of the 
protein N-terminal and its ability to anchor to the mem-
brane (Campos et al. 1997). This variant was only present 
in species from the Pan genus (Table 1). Species contain-
ing m.3308T>C showed a methionine to threonine change 
and alternative initiation codon at position 3 as seen in 
humans (Opdal et al. 1999). The alignments revealed an 
L0d haplogroup marker, 4232T>C, present only in the 
non-human sequences containing the m.3308T>C vari-
ant. The L0d haplogroup is predominant within the South 
African Khoisan population. It is one of the deepest rooted 
haplogroups within the anatomically modern human 
mtDNA lineage (van Oven and Kayser 2009). A single 
L0d sequence containing both m.3308T>C and 4232T>C, 
with no reported disease association, is present on the 
GenBank database, EU092708.1.
Both m.10191T>C and m.14487T>C human pathogenic 
variants were conserved in species of fish (Table 1). Simi-
larly, when studying mt-tRNA-Leu(UUR), three variants 
were found to be confined to species of fish, one of which 
was deemed pathogenic (Queen et al. 2017). In all these 
species of fish, further variation was seen within the codons 
containing these pathogenic variants. Hypophthalmichthys 
molitrix showed variation within the codon which may be 
sufficient to repress the penetrance of the m.10191T>C vari-
ant. Similarly, in species containing m.14487T>C, variation 
was seen at the first base of the codon, resulting in an M > G 
amino acid change rather than the M > V change seen in 
humans.
It is important to recall that the mtDNA complex 1 genes 
only account for seven of the 45 subunits that constitute 
complex I. Therefore, it is possible that nuclear variability 
contributes to the masking of pathogenic variants within 
the mt-protein-encoding genes in some contexts (van der 
Westhuizen et al. 2015). The interdependent nature of mito-
nuclear proteins suggests nuclear variability, particularly in 
the supernumerary subunits, could resolve stability within 
the protein complexes (Mimaki et al. 2012). The elegant 
study of Loewen and Ganetzky (2018) is an important exem-
plar when considering nuclear–mitochondrial interactions. 
Their paper showed that that the phenotypic severity of a 
complex 1 mutation causing Leigh syndrome phenotype 
varies depending on the mitochondrial background. Leigh 
syndrome is a severe disorder that is characterised by early, 
progressive neurodegeneration, with both intellectual and 
motor difficulties and deficient mitochondrial respiration 
(Lake et al. 2016).
In the current study, the pathogenicity variants were 
classified using accepted methodology as report (Mitch-
ell et al. 2006), but it should be noted this method has not 
been reviewed in recent years. It is important to note the 
original method for the classification of mtDNA variants in 
Disease association is listed in accordance with reports from the Mitomap online database (Accessed: 02-2017)
Table 1  (continued)
Gene Position Variant Disease association Status Species
ND5 13,514 A-G Leigh disease, MELAS Probably pathogenic Clupea harengus
13,528 A-G LHON, MELAS Probably pathogenic Macaca fascicularis, Mus musculus, Rattus 
norvegicus, Myodes glareolus, Anguilla 
anguilla, Bos grunniens, Clupea harengus, 
Hypophthalmichthys molitrix, Hypophthal-
michthys nobilis, Balaenoptera physalus, 
Bison bison, Sus scrofa, Syncerus caffer, 
Tursiops truncatus
13,708 G-A LHON, increased MS risk Probably pathogenic Pan paniscus, Pan troglodytes schweinfurthii, 
Pan troglodytes verus, Anguilla anguilla, 
Anguilla rostrata, Coregonus lavaretus, 
Hypophthalmichthys molitrix, Hypophthal-
michthys nobilis, Urocyon littoralis clemente
ND6 14,453 G-A Leigh disease, MELAS Probably pathogenic Anguilla anguilla, Clupea harengus, Corego-
nus lavaretus, Gallus gallus, Glyphis glyphis, 
Hypophthalmichthys molitrix
14,459 G-A LHON with dystonia, Leigh disease Probably pathogenic Gallus gallus
14,482 C-A LHON Probably pathogenic Urocyon littoralis clemente, Ursus spelaeus
14,487 T-C Dystonia, Leigh disease, Ataxia, Ptosis, 
Epilepsy
Definitely pathogenic Anguilla anguilla, Anguilla rostrata, Clupea 
harengus, Coregonus lavaretus, Glyphis 
glyphis, Hypophthalmichthys nobilis
14,502 T-C LHON Probably pathogenic Macaca fascicularis, Balaenoptera physalus, 
Orcinus orca
14,596 A-T LHON Probably pathogenic Ursus spelaeus
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the context of mt-tRNA mutations (McFarland et al. 2004) 
was found to be too conservative upon review (Yarham 
et al. 2012). Therefore, a review of the method presented 
by Mitchell et al. (2006) might be merited, particularly in 
light of a growing understanding of nuclear–mitochondrial 
interactions, as highlighted in recent works (Loewen and 
Ganetzky 2018), and with there being 19 variants that were 
classified as probably pathogenic in the species studied, see 
Table 1.
These data, along with the previous findings in mt-tRNA-
Leu (UUR) (Queen et al. 2017), would suggest that sequence 
context is important in the expression and penetrance of 
mtDNA disease. However, it also suggests this phenomenon 
might be more important in mt-tRNA genes compared to 
mt-protein-encoding genes. This finding is perhaps linked 
to the differing effectiveness of purifying selection in the 
removal of deleterious or mildly deleterious variants in the 
Table 2  Human mitochondrial variants present in one or more chor-
date species with amino acid change, conservation index and Gen-
Bank frequency derived from MitoMaster SNV query tool (Lott et al. 
2013a, b)
Gene Position Variant Amino 
acid 
change
Conserva-
tion index 
(%)
GenBank 
frequency
ND1 3308 T-C M-T 84.44 346
3310 C-T P-S 13.33 11
3394 T-C Y-H 93.33 602
3890 G-A R-Q 100 1
3995 A-G N-S 97.78 18
4171 C-A L-M 93.33 2
4216 T-C Y-H 24.44 4516
3316 G-A A-T 4.44 435
3337 G-A V-M 24.44 72
3340 T-C P-S 86.67 3
3397 A-G M-V 91.11 133
3421 G-A V-I 28.89 69
3496 G-T A-S 15.56 11
3497 C-T A-V 15.56 140
3644 T-C V-A 100 198
3700 G-A A-T 93.33 3
3736 G-A V-I 93.33 74
3745 G-A A-T 88.89 97
3796 A-G T-A 71.11 217
3833 T-A L-Q 40 0
3866 T-C I-T 86.67 127
4132 G-A A-T 13.33 7
4142 G-A R-Q 100 0
ND2 4640 C-A I-M 26.67 132
4648 T-C F-S 95.56 1
4833 A-G T-A 17.78 428
4917 A-G N-D 91.11 2160
5178 C-A L-M 22.22 2211
5452 C-T T-M 51.11 13
5460 G-A A-T 4.44 2956
ND3 10,158 T-C S-P 31.11 0
10,191 T-C S-P 17.78 0
10,086 A-G N-D 86.67 414
10,237 T-C I-T 100 68
10,398 A-G T-A 51.11 20,416
ND4 11,240 C-T L-F 97.78 0
11,696 G-A V-I 6.67 275
11,084 A-G T-A 86.67 190
11,232 T-C L-P 93.33 0
11,253 T-C I-T 42.22 239
11,874 C-A T-N 77.78 0
11,919 C-T S-F 86.67 0
11,994 C-T T-I 31.11 0
12,026 A-G I-V 62.22 216
ND4L 10,663 T-C V-A 88.89 1
10,680 G-A A-T 93.33 18
Table 2  (continued)
Gene Position Variant Amino 
acid 
change
Conserva-
tion index 
(%)
GenBank 
frequency
ND5 13,514 A-G D-G 100 0
13,528 A-G T-A 40 38
13,708 G-A A-T 33.33 3262
12,338 T-C M-T 71.11 141
12,361 A-G T-A 13.33 252
12,397 A-G T-A 20 318
12,622 G-A V-I 82.22 10
12,634 A-G I-V 97.78 130
12,811 T-C Y-H 55.56 547
13,094 T-C V-A 100 1
13,135 G-A A-T 8.89 429
13,511 A-T K-M 100 0
13,831 C-A L-M 31.11 3
13,849 A-C N-H 62.22 0
13,967 C-T T-M 13.33 139
14,063 T-C I-T 13.33 24
14,091 A-T K-N 100 0
ND6 14,453 G-A A-V 93.33 0
14,459 G-A A-V 88.89 3
14,482 C-A M-I 31.11 2
14,487 T-C M-V 97.78 0
14,502 T-C I-V 77.78 168
14,596 A-T I-M 84.44 0
14,163 C-T A-T 15.56 12
14,279 G-A S-L 46.67 6
14,325 T-C N-D 17.78 49
14,319 T-C N-D 40 55
14,340 C-T V-M 17.78 21
14,439 G-A P-S 95.56 0
14,482 C-G M-I 31.11 0
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protein-encoding genes and the mt-tRNA’s at the mitochon-
drial bottleneck (Stewart et al. 2008). Stewart et al. (2008) 
reported a rapid and strong elimination of nonsynonymous 
changes in protein-coding genes in a mouse model, which 
is the hallmark of purifying selection, but the removal of 
changes in the mt-tRNA and rRNA genes was much slower 
taking many more generations. The apparent tighter selec-
tive constraints on mtDNA protein-encoding genes is likely 
related to the multimeric nature of the mtDNA complexes 
and the need to maintain nuclear–mitochondrial compat-
ibility (Mimaki et al. 2012). It might also be that the pri-
mary bottleneck occurs at a time when there are low levels 
of protein synthesis, but high respiratory demand, perhaps 
explaining the lack of efficacy of this selective process in the 
context of some pathogenic mt-tRNA mutations that are fre-
quently transmitted in humans (Elson et al. 2009). It should 
also be noted that in adults presenting with disease resulting 
from mtDNA point mutations, mutations of the mt-tRNA’s 
are more common than those of the protein-encoding genes, 
with the m.3243A > G mutation being by far the most com-
mon (Gorman et al. 2015), while mutations of the complex 
1 genes being frequently associated with severe paediatric 
disorders such a Leigh syndrome (Lake et al. 2016).
Nevertheless, this study has significant implications for 
diagnostic investigations in patients from understudied pop-
ulation groups as it supports the argument that there might 
not be a universal list of pathogenic variants for all lineages 
(van der Westhuizen et al. 2015). Together with the findings 
of Queen et al. (2017), it highlights the dangers of investi-
gating variants in isolation without considering haplogroup 
context and assuming that what is true in one haplogroup 
context will be true in another. This work and that of others 
(Queen et al. 2017; Kern and Kondrashov 2004; Loewen 
and Ganetzky 2018) provides significant motivation for 
conducting sequencing or survey studies investigating the 
prevalence of common point mutations in understudied 
population groups, similar to that conducted previously in 
European populations (Elliott et al. 2008). Much work has 
been done in a number of Asian populations to better under-
stand importance of sequence context, which has revealed 
population-specific mutations and lineage-specific effects (Ji 
et al. 2014; Zhang et al. 2012). In order to achieve compara-
ble diagnostic abilities in all populations, additional studies 
are required to expand our knowledge of population varia-
tion in less studied populations, and gathering the laboratory 
based data to work-up mutations in individuals from these 
understudied populations. If it is demonstrated that haplo-
group context is of greater importance in the expression and 
penetrance of mtDNA mutations than previously appreci-
ated, then perhaps the role, if any, of mtDNA variation in 
complex traits might also be population specific.
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Fig. 1  Consensus sequence alignments from species containing path-
ogenic variants. a Consensus sequences from the Pan genus demon-
strating the presence of the 3308T>C variant. b Consensus sequences 
from species of fish demonstrating the presence of the 14487T>C 
variant. c Consensus sequences from Hypophthalmichthys moli-
trix demonstrating the presence of the 10191T>C variant. All con-
sensus sequences were derived from the individual species multiple 
sequence alignments
 Journal of Molecular Evolution
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